
Francesca Cottini MD
Hematologic Oncology
Assistant Professor, Division of Hematology
Join to View Full Profile
400 W 12th AveColumbus, OH 43210
Phone+1 614-292-6818
Fax+1 614-293-7526
Dr. Cottini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a hematologist who specializes in the treatment of patients with plasma cell disorders, such as multiple myeloma and amyloidosis. I completed my residency and hematology/medical oncology fellowship at The Ohio State University, where I became passionate about how the immune system affects myeloma growth, response to therapy and risk of infections.
My laboratory research combines Multiple Myeloma (MM) biology and immunology to focus on the identification and validation of novel therapeutical targets, while my clinical research aims at defining strategies to improve the safety of autologous stem cell transplant or anti-MM therapies.
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2017 - 2020
- Ohio State University HospitalResidency, Internal Medicine, 2015 - 2017
- Universita San RaffaeleClass of 2009, MD, Cum laude
Certifications & Licensure
- OH State Medical License 2018 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- AACR Scholar-in-Training Award American Association for Cancer Research, 2014, 2017
- Young Fellow Award International Myeloma Foundation, 2015
- TRTH participant EHA-ASH Translational Research Training in Hematology, 2014
Publications & Presentations
PubMed
- Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies.Elvira Umyarova, Charles Pei, William Pellegrino, Qiuhong Zhao, Nidhi Sharma
Journal of Hematology & Oncology. 2025-03-18 - 1 citationsCREB1 promotes expression of immune checkpoint HLA-E leading to immune escape in multiple myeloma.Aya Ismael, Allen J Robinette, Laila Huric, Jamie Schuetz, Kameron Dona
Leukemia. 2024-08-01 - 1 citationsCD56 expression predicts response to Daratumumab-based regimens.Allen J Robinette, Laila Huric, Kameron Dona, Don Benson, Francesca Cottini
Blood Cancer Journal. 2024-04-12
Grant Support
- Investigating CD56 signaling in multiple myeloma growth and immune escapeOHIO STATE UNIVERSITY2022–2027
Professional Memberships
- Member
- Member
- Member
- Member
- Member
- International Myeloma SocietyMember
Other Languages
- Italian, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: